Fosun International Posts Robust 1H2026 Financial Results

Fosun International has released its interim financial results for the first half of 2026, highlighting significant improvements in revenue and profitability. Total revenue amounted to RMB86.96 billion, with a net profit of RMB1.72 billion, marking a 160.3% year-on-year increase. Fosun attributes this growth to its strategic focus on core business areas, including pharmaceuticals, healthcare, and cultural tourism.

The Group's revenue from overseas operations rose by 5.3%, reaching RMB49.16 billion, which demonstrates the effectiveness of its globalization strategy. Innovation remains a cornerstone, with Fosun investing RMB4.2 billion in technology advancements.

Fosun's financial health appears robust, bolstered by a strategic divestment of non-core assets, resulting in over RMB12.0 billion in proceeds. Liquidity and debt management remain strong, with cash reserves increasing to RMB61.214 billion.

Fosun's environmental, social, and governance (ESG) performance garnered international recognition, with its MSCI ESG rating upgraded to AAA. Looking forward, Fosun aims to restore annual profits to RMB10 billion through continued innovation and global expansion.